International repercussions of the FIFA corruption scandal. China outlines a new military strategy in the South China Sea. And the Iraqi military launches a new offensive near Ramadi. A panel of journalists joins Diane for analysis of the week's top international news stories.
Talking about death and dying is never easy. Many of us cling to the childhood belief that parents are invincible. But avoiding an end-of life conversation with a loved one could have tragic consequences. It might mean a surrogate who has different values from your mother could end up making decisions for her. Or that your uncle won’t qualify for Medicaid because he didn’t understand the process. Armed with basic facts and good listening skills, it’s possible to create a strategy that gives a loved one comfort and provides caregivers with peace of mind. Diane and her guests explore how to begin discussions about end-of life care.
- Charles Sabatino director of the Commission on Law and Aging, American Bar Association.
- Sue Belanger clinical ethicist and adjunct assistant professor at Georgetown University School of Nursing and Health Studies, and director of education, training and research at Sibley Memorial Hospital in Washington, D.C.
- Janis Abrahms Spring clinical psychologist and author of "Life with Pop: Lessons on Caring for an Aging Parent" and "After the Affair."
Most Recent Shows
The Justice Department charges FIFA soccer officials with corruption. More contenders enter the already-crowded 2016 presidential race. And former House Speaker Dennis Hastert is indicted for violating banking laws and lying to the FBI. A panel of journalists joins Diane for analysis of the week's top national news stories.
Research psychologist Penelope Leach is known for her best-selling guides on child development, including "Babyhood" and "Your Baby and Child." In her latest book, she explains what the latest research says about helping children cope with separation and divorce.
More than half a million Americans have annual prescription drug bills of at least $50,000. Please join us to discuss what's behind soaring drug costs and the push for new pricing models.